Invisalign® System with Mandibular Advancement
Launched by ALIGN TECHNOLOGY, INC. · Oct 18, 2024
Trial Information
Current as of May 06, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special type of orthodontic treatment called the Invisalign® System, which includes a feature for helping the lower jaw move forward. The main focus is to see how comfortable participants are with their aligners and to check how well the system works for improving dental issues like Class II malocclusion, which means the upper teeth stick out more than the lower teeth.
To join the trial, participants need to be eligible for this specific type of Invisalign treatment and must not have certain dental issues or health conditions, such as active gum disease or a history of seizures. The trial is open to people aged between 10 and 15 years old, and anyone interested can expect to provide feedback on their experience with the aligners. The study is currently looking for participants, and it aims to help improve orthodontic treatments for those with similar dental challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Subject must be eligible for Invisalign treatment with mandibular advancement
- Exclusion Criteria:
- • Subject's dentition not compatible with device or allergy to device materials
- • Subject who is pregnant, has active caries, periodontal disease, TMD, root resorption, has HAE (hereditary angioedema), has been diagnosed with epilepsy or any other seizure disorder
About Align Technology, Inc.
Align Technology, Inc. is a leading global medical device company specializing in the design, manufacture, and marketing of innovative orthodontic products and services. Renowned for its pioneering Invisalign clear aligner system, Align Technology leverages advanced 3D imaging and digital scanning technologies to provide orthodontic solutions that enhance patient outcomes and improve the efficiency of dental practices. With a commitment to research and development, Align Technology actively conducts clinical trials to advance its product offerings and explore new applications in dental and orthodontic care, ultimately aiming to transform the way orthodontics is delivered worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, British Columbia, Canada
Saint John, New Brunswick, Canada
Brampton, Ontario, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported